Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 10 of 10 for “"Treatment Delay"”.
-
Understanding Cancer Treatment Delay and Survival
Background: The diagnosis to treatment interval (DTI) is important for patient disease management and survival among patients with cancer. Guidance for conducting studies examining the association between the DTI and overall survival (OS) is needed to address potential bias, improve methodological …
-
Tuberculosis treatment delay in adults and household transmission to children: a community-based study in a setting with high burden of tuberculosis and HIV
… transmission through rapid diagnosis and treatment initiation of infectious TB cases. With increasing delay in the diagnosis and treatment of pulmonary TB, disease is likely to progress, leading to progressive lung cavitation and increased sputum bacillary load, likely increasing TB …
-
INVASIVE BLADDER CANCER - Aspects on staging and prognosis
… is considerable debate regarding the effects of delay on prognosis, lymph node staging and detection and staging of transitional cell carcinoma (TCC) involving the prostatic urethra and prostate in males. This thesis is based on investigations of the impact of diagnostic and treatment delay on …
-
Delay in accessing healthcare after transient ischaemic attack and minor stroke : the role of primary care in the problem and the solution
… with a clinical rule and reduced with urgent treatment. Delay in accessing assessment and vascular risk factor modification should therefore be as short as possible, yet little is known in the UK about where patients seek care and the key influences of the time to contact healthcare services. …
-
Clinical outcomes in patients with paracetamol ingestion treated with a two-bag n-acetylcysteine regimen in the emergency centre of khayelitsha hospital
… (32%) were less in the two-bag regimen. A delay in initiating the first NAC infusion occurred in 22 (38.6%) patients. Forty adverse effects were recorded in 22 (38.6%) patients and a higher proportion occurred in the two-bag regime (44.0% vs. 34.4%). Nausea and vomiting occurred frequently …
-
Microelectromechanical handheld laser-scanning confocal microscope: application to breast cancer imaging
… prognosis, while reducing screening costs, treatment delay, and occurrences of unnecessary and potentially harmful medication. This dissertation investigates handheld instrumentation for laser-scanning confocal microscopy (LSCM) and its applicability to breast cancer detection and subsequent …
-
Delay in provision of breast cancer care in patients seen at a district hospital diagnostic breast unit in South Africa
Background: There is evidence to show that delays in breast cancer management are detrimental to patient outcome. The aim of this study was to determine time trends and causes of delay in a newly established diagnostic breast clinic based at a district hospital in South Africa. Method: All patients …
-
Treatment Decision Making in African American Women Diagnosed with Triple Negative Breast Cancer
… attention is extended to decisions regarding treatment. These efforts include, but are not limited to, immediate emotional and mental management, resource availability, belief in treatment outcomes, and consideration of short and long-term quality of life outcomes. Treatment decision making …
-
Treatment-resistant ophthalmoplegia in myasthenia gravis: Clinical, molecular and functional studies of patient-derived orbital tissues
… receptor positive MG (AChR-MG), may manifest treatmentresistant extraocular muscle weakness despite the use of standard immune therapies. The pathogenetic mechanisms involved in the development of treatment-resistant ophthalmoplegia in MG are still unknown and no effective treatment currently …
-
CLINICAL VALIDATION OF 371 MICRO-RNA USE IN SMALL TESTICULAR MASSES AND IN STAGE IIA AND IIB<3CM TESTICULAR GERM CELL TUMORS
… advanced TGTCs is still complex and the risk of treatment delay or, conversely, of overtreatment is high. According to this assumption we focused on two different TGCTs patients categories to test a new biomarker that may allow to improve TGCTs management. 371a-p microRNA showed the ability to …